Indivior (LON:INDV) Trading Down 17% – Should You Sell?

Shares of Indivior PLC (LON:INDV) were down 17% during trading on Thursday . The stock traded as low as GBX 548.71 ($6.90) and last traded at GBX 720.60 ($9.07). Approximately 2,904,792 shares were traded during mid-day trading, an increase of 294% from the average daily volume of 737,710 shares. The stock had previously closed at GBX 868 ($10.92).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($22.65) target price on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Price Performance

The stock’s fifty day moving average price is GBX 928.06 and its 200-day moving average price is GBX 853.71. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The firm has a market cap of £1.18 billion, a PE ratio of -624.35, a P/E/G ratio of -5.57 and a beta of 0.19.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.